Exelixis Inc Increase (Decrease) in Restricted Cash and Investments
Exelixis Inc (EXEL) reported Increase (Decrease) in Restricted Cash and Investments of -$14.65 million for the 12-month period ending 2017-12-29, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments · last filed 2018-02-26
- Exelixis Inc increase (decrease) in restricted cash and investments for the quarter ending 2017-12-29 was -$4.00M.
- Exelixis Inc increase (decrease) in restricted cash and investments for the quarter ending 2017-09-30 was -$5.00M.
- Exelixis Inc increase (decrease) in restricted cash and investments for the quarter ending 2017-06-30 was -$2.15M.
- Exelixis Inc increase (decrease) in restricted cash and investments for the quarter ending 2017-03-31 was -$3.50M.
- Exelixis Inc increase (decrease) in restricted cash and investments for fiscal 2017 was -$14.65M.
- Exelixis Inc increase (decrease) in restricted cash and investments for fiscal 2016 was -$7.15M.
- Exelixis Inc increase (decrease) in restricted cash and investments for fiscal 2016 was -$7.15M.
- Exelixis Inc increase (decrease) in restricted cash and investments for fiscal 2016 was -$19.79M.
| Period end | Increase (Decrease) in Restricted Cash and Investments 3 month | Increase (Decrease) in Restricted Cash and Investments 6 month | Increase (Decrease) in Restricted Cash and Investments 6 month as first filed | Increase (Decrease) in Restricted Cash and Investments 9 month | Increase (Decrease) in Restricted Cash and Investments 9 month as first filed | Increase (Decrease) in Restricted Cash and Investments 12 month | Increase (Decrease) in Restricted Cash and Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-29 | -$4.00M derived: 10-K 12 month − 3 quarters · filed 2018-02-26 | -$9.00M derived: sum of 2 quarters · filed 2018-02-26 | -$11.15M derived: sum of 3 quarters · filed 2018-02-26 | -$14.65M 10-K · filed 2018-02-26 | |||
| 2017-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$7.15M derived: sum of 2 quarters · filed 2017-11-01 | -$10.65M 10-Q · filed 2017-11-01 | -$15.15M derived: sum of 4 quarters · filed 2017-11-01 | |||
| 2017-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$5.65M 10-Q · filed 2017-08-02 | -$10.15M derived: sum of 3 quarters · filed 2017-08-02 | -$10.15M derived: sum of 4 quarters · filed 2017-11-01 | |||
| 2017-03-31 | -$3.50M 10-Q · filed 2017-05-01 | -$8.00M derived: sum of 2 quarters · filed 2017-05-01 | -$8.00M derived: sum of 3 quarters · filed 2017-11-01 | -$8.65M derived: sum of 4 quarters · filed 2017-11-01 | |||
| 2016-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$4.50M derived: sum of 2 quarters · filed 2017-11-01 | -$5.15M derived: sum of 3 quarters · filed 2017-11-01 | -$7.15M 10-K · filed 2017-02-27 | |||
| 2016-12-30 | -$7.15M 10-K · filed 2018-02-26 | ||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$646.00K derived: sum of 2 quarters · filed 2017-11-01 | -$2.65M 10-Q · filed 2017-11-01 | -$5.68M derived: sum of 4 quarters · filed 2017-11-01 | |||
| 2016-06-30 | -$646.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$2.65M 10-Q · filed 2017-08-02 | -$5.68M derived: sum of 3 quarters · filed 2017-08-02 | -$10.19M derived: sum of 4 quarters · filed 2017-08-02 | |||
| 2016-03-31 | -$2.00M 10-Q · filed 2017-05-01 | -$5.04M derived: sum of 2 quarters · filed 2017-05-01 | -$9.55M derived: sum of 3 quarters · filed 2017-05-01 | -$11.04M derived: sum of 4 quarters · filed 2017-05-01 | |||
| 2016-01-01 | -$19.79M 10-K · filed 2018-02-26 | ||||||
| 2015-12-31 | -$3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$7.54M derived: sum of 2 quarters · filed 2017-02-27 | -$9.04M derived: sum of 3 quarters · filed 2017-02-27 | -$19.79M 10-K · filed 2017-02-27 | |||
| 2015-09-30 | -$4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$6.01M derived: sum of 2 quarters · filed 2016-11-03 | -$16.75M 10-Q · filed 2016-11-03 | -$16.71M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$12.25M 10-Q · filed 2016-08-03 | -$12.20M derived: sum of 3 quarters · filed 2017-02-27 | -$21.82M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-31 | -$10.75M 10-Q · filed 2016-05-04 | -$10.71M derived: sum of 2 quarters · filed 2017-02-27 | -$20.32M derived: sum of 3 quarters · filed 2017-02-27 | -$24.50M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$9.58M derived: sum of 2 quarters · filed 2017-02-27 | -$13.76M derived: sum of 3 quarters · filed 2017-02-27 | -$20.35M 10-K · filed 2017-02-27 | |||
| 2014-09-30 | -$9.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$13.80M derived: sum of 2 quarters · filed 2015-11-10 | -$20.40M 10-Q · filed 2015-11-10 | -$21.70M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$10.78M 10-Q · filed 2015-08-11 | -$12.08M derived: sum of 3 quarters · filed 2016-02-29 | -$18.18M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$6.60M 10-Q · filed 2015-04-30 | -$7.90M derived: sum of 2 quarters · filed 2016-02-29 | -$14.00M derived: sum of 3 quarters · filed 2016-02-29 | -$17.22M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$7.40M derived: sum of 2 quarters · filed 2016-02-29 | -$10.62M derived: sum of 3 quarters · filed 2016-02-29 | -$17.27M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$9.32M derived: sum of 2 quarters · filed 2014-11-04 | -$15.97M 10-Q · filed 2014-11-04 | -$17.27M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | -$3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$9.87M 10-Q · filed 2014-07-31 | -$11.17M derived: sum of 3 quarters · filed 2015-03-02 | -$15.37M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-03-31 | -$6.65M 10-Q · filed 2014-05-01 | -$7.95M derived: sum of 2 quarters · filed 2015-03-02 | -$12.15M derived: sum of 3 quarters · filed 2015-03-02 | -$11.64M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$5.50M derived: sum of 2 quarters · filed 2015-03-02 | -$5.00M derived: sum of 3 quarters · filed 2015-03-02 | -$5.50M 10-K · filed 2015-03-02 | |||
| 2012-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$3.69M derived: sum of 2 quarters · filed 2013-10-30 | -$4.20M 10-Q · filed 2013-10-30 | $35.99M 10-Q · filed 2012-11-07 | -$10.10M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | $504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | -$132.00K 10-Q · filed 2012-08-02 | -$5.90M derived: sum of 3 quarters · filed 2014-02-20 | -$5.90M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-03-31 | -$504.00K 10-Q · filed 2013-05-07 | -$6.40M derived: sum of 2 quarters · filed 2014-02-20 | -$6.40M derived: sum of 3 quarters · filed 2014-02-20 | -$6.40M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | -$5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$5.90M derived: sum of 2 quarters · filed 2014-02-20 | -$5.90M derived: sum of 3 quarters · filed 2014-02-20 | -$8.10M 10-K · filed 2014-02-20 | -$2.20M 10-K · filed 2012-02-22 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | -$2.20M 10-Q · filed 2012-11-07 | -$10.30M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$2.20M 10-Q · filed 2012-08-02 | -$10.30M derived: sum of 3 quarters · filed 2013-02-21 | -$10.30M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-03-31 | -$2.20M 10-Q · filed 2012-05-03 | -$10.30M derived: sum of 2 quarters · filed 2013-02-21 | -$10.30M derived: sum of 3 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$8.10M derived: sum of 2 quarters · filed 2013-02-21 | -$8.14M 10-K · filed 2013-02-21 | -$45.00K 10-K · filed 2012-02-22 | |||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$45.00K 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | -$45.00K 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | $2.43M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |